ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,131
Screening encounters
3,594
Diagnostic referrals
687
Outstanding pathways
262

Screening pathway

  1. Screening3,594Encounters
  2. Positive finding1,237Documented findings
  3. Referral687Diagnostic referrals
  4. Follow-up795Diagnostic visits
  5. Outcome425Resolved pathways

Stage totals use different units. Pending pathways: 262. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0301 · EXP-0301Synthetic · Site D

Full participant history through 2026-07-15, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-07-05
  4. · Diagnostic referral · EXP-0301-T-R
  5. · Contact attempt · Unsuccessful
  6. · Barrier documented · Appointment coordination
  7. · Diagnostic booking · Initial booking
  8. · Contact attempt · Reached
  9. · Barrier documented · Transport difficulty
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-0301-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2026-04-04
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3131 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0231 · Expanded synthetic participant 0231Site A — Urban Referral Hub
EXP-0232 · Expanded synthetic participant 0232Site C — Rural Outreach Programme
EXP-0233 · Expanded synthetic participant 0233Site C — Rural Outreach Programme
EXP-0238 · Expanded synthetic participant 0238Site D — Community Engagement Programme
EXP-0239 · Expanded synthetic participant 0239Site A — Urban Referral Hub
EXP-0240 · Expanded synthetic participant 0240Site B — Peri-Urban Access Programme
EXP-0243 · Expanded synthetic participant 0243Site D — Community Engagement Programme
EXP-0245 · Expanded synthetic participant 0245Site C — Rural Outreach Programme
EXP-0247 · Expanded synthetic participant 0247Site C — Rural Outreach Programme
EXP-0248 · Expanded synthetic participant 0248Site E — Resource-Constrained Navigation Programme
EXP-0249 · Expanded synthetic participant 0249Site E — Resource-Constrained Navigation Programme
EXP-0250 · Expanded synthetic participant 0250Site C — Rural Outreach Programme
EXP-0251 · Expanded synthetic participant 0251Site A — Urban Referral Hub
EXP-0252 · Expanded synthetic participant 0252Site A — Urban Referral Hub
EXP-0253 · Expanded synthetic participant 0253Site D — Community Engagement Programme
EXP-0256 · Expanded synthetic participant 0256Site A — Urban Referral Hub
EXP-0258 · Expanded synthetic participant 0258Site A — Urban Referral Hub
EXP-0259 · Expanded synthetic participant 0259Site D — Community Engagement Programme
EXP-0260 · Expanded synthetic participant 0260Site E — Resource-Constrained Navigation Programme
EXP-0261 · Expanded synthetic participant 0261Site A — Urban Referral Hub
EXP-0262 · Expanded synthetic participant 0262Site B — Peri-Urban Access Programme
EXP-0264 · Expanded synthetic participant 0264Site B — Peri-Urban Access Programme
EXP-0265 · Expanded synthetic participant 0265Site C — Rural Outreach Programme
EXP-0266 · Expanded synthetic participant 0266Site D — Community Engagement Programme
EXP-0267 · Expanded synthetic participant 0267Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1439
HPV DNA
1632
Cytology
523

Navigation activity

Barrier documented
588
Contact attempt
1012
Navigation intervention
246
Diagnostic booking
845
Diagnostic visit
795

Documented barriers

Contact difficulty
192
Transport difficulty
185
Appointment coordination
211

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.